Mastitis is a serious cause of loss to the world's dairy industries, resulting in reduced milk production and quality.
Bovine Mastitis: Products and markets focuses on this important sector of the animal health industry, enabling you to access information on the aetiology and different types of mastitis, herd health and demographics and milk production in the main country markets.
The report provides details of the established and developing markets within the Mercosur and NAFTA trade blocs and includes market profiles for:
* Argentina
* Brazil
* Colombia
* France
* Germany
* Italy
* Japan
* Mexico
* South Africa
* Sweden
* UK
* US
* Venezuela
This report gives market values for mastitis products for the countries profiled, and includes important information on the latest technology developments. Products discussed include antibiotics, hormones and vaccines, and an outline of the market for each product type is provided. Bovine Mastitis: Products and markets includes profiles of the main companies involved in the mastitis products industry, giving sales figures and useful product information.
Companies profiled: Boehringer Ingelheim; Fort Dodge; Hoechst Roussel Vet; Intervet; Merial; Novartis; Norbrook; Pfizer; Pharmacia & Upjohn; Schering-Plough.
PUBLISHED: JUNE 1998
REF: SR173E
PAGES: 65
PRICE: £295/$620/¥71,000
CONTENTS
LIST OF TABLES
INTRODUCTION
CHAPTER 1 MASTITIS: PATHOGENS AND GLOBAL INCIDENCE
1.1 Mastitis-causing pathogens
1.1.1 Contagious mastitis pathogens
1.1.2 Environmental mastitis pathogens
1.2 Mastitis types
1.3 Global incidence of mastitis
1.3.1 North America
1.3.2 Latin America
1.3.3 The EU
CHAPTER 2 MASTITIS PRODUCTS
2.1 Antibiotics and related products
2.1.1 Resistance
2.1.2 Lactating cow therapy
2.1.3 Dry cow therapy
2.1.4 Hygiene products
2.1.5 Other mastitis therapy preparations
2.2 Hormones
2.2.1 Oxytocin
2.2.2 Recombinant bovine somatotropin
2.3 Vaccines
2.4 Cytokines
2.5 Diagnostics for mastitis
2.6 Breeding for resistance
2.7 Nutrition
CHAPTER 3 MARKETS FOR MASTITIS PRODUCTS
3.1 World milk production
3.1.1 North America
3.1.2 Latin America
3.1.3 The EU
3.1.4 Australasia
3.1.5 India
3.1.6 Asia
3.2 Mastitis products: international markets
3.2.1 North America
3.2.2 Latin America
3.2.3 The EU
3.2.4 Japan
3.2.5 South Africa
CHAPTER 4 COMPANY PROFILES
4.1 Boehringer Ingelheim
4.1.1 Boehringer Ingelheim's mastitis products
4.2 Fort Dodge
4.2.1 Fort Dodge's mastitis products
4.2.2 Merger activity
4.3 Hoechst Roussel Vet
4.3.1 HR Vet's mastitis products
4.4 Intervet
4.4.1 Intervet's mastitis products
4.5 Merial
4.5.1 Merial's mastitis products
4.6 Norbrook Laboratories Ltd
4.6.1 Norbrook's mastitis products
4.6.2 Future development
4.7 Pfizer
4.7.1 Pfizer's mastitis products
4.8 Pharmacia & Upjohn
4.8.1 Pharmacia & Upjohn's mastitis products
4.8.2 Future developments
4.9 Schering-Plough
4.9.1 Schering-Plough's mastitis products
4.10 Other companies with interest in mastitis products
4.10.1 Biotay
4.10.2 G C Hanson Manufacturing Company
4.10.3 Laboratories Aranda
BIBLIOGRAPHY
REFERENCES
LIST OF TABLES
Table 1.1 Micro-organisms isolated from Brazilian bovine mastitis cases in 1997
Table 1.2 Evolution of pathogens isolated from clinical mastitis cases in Argentina
Table 1.3 Bacteria in Finnish milk samples in 1995
Table 2.1 Examples of intramammary products available in the UK
Table 2.2 Various teat and udder disinfectants available in the UK
Table 2.3 Mastitis vaccines currently available
Table 2.4 Mastitis diagnostics currently available
Table 3.1 World dairy cow numbers 1992-1997
Table 3.2 World milk production, 1997
Table 3.3 World liquid milk consumption, 1996
Table 3.4 Brazilian milk production by state 1990-1996
Table 3.5 Cows' milk collected in the EU
Table 3.6 US animal health sales in 1996
Table 3.7 Intramammary sales worldwide, 1997
© PJB Publications Ltd. 2000 All rights reserved. |